Skip to content
stoqly
en · USD

Appearance

Language

Currency

Popular

All currencies

Data is in US dollars, converted at the exchange rate of Oct 28, 2026.

Sign in

James Kihara

Principal Accounting Officer, Acadia Pharmaceuticals

Bought, 12 months
$0.0M
Sold, 12 months
$0.6M
Companies
1
Latest trade
Jun 26, 2026

Companies

Acadia PharmaceuticalsPrincipal Accounting Officer −$0.6M

Trades

ACAD Sold 11,421 shares at $26.08 · planned $0.3M Jun 26 Form 4
ACAD Sold 5,401 shares at $21.18 $0.1M May 26 Form 4
ACAD Sold 1,332 shares at $21.79 · planned $0.0M May 4 Form 4
ACAD Sold 1,030 shares at $22.20 · planned $0.0M Apr 7 Form 4
ACAD Sold 1,109 shares at $21.65 · planned $0.0M Mar 26 Form 4
ACAD Sold 833 shares at $21.47 · planned $0.0M Mar 25 Form 4
ACAD Sold 4,084 shares at $23.69 · planned $0.1M Nov 18 Form 4

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.

↑ ↓ to move · ↵ to open